Moderna Looking At $100 COVID-19 Vaccines
September 9, 2022
With the US federal government ending free COVID-19 vaccines by the end of 2022, Moderna has begun deliberating the cost it will charge for the shots on the commercial market. Arpa Garay, COO of Moderna, spoke with investors Tuesday, September 8th, informing them of the company’s move towards value-based pricing. The proposed $100 price tag would be triple that paid by the US government during the ongoing pandemic.
According to Zachary Brennan, “But insurance will still likely cover much of the cost of the shots for many after switching over to a commercial market, and the US will still dole out about 170 million of the upcoming bivalent boosters for free this fall and winter, HHS’ Assistant Secretary for Preparedness and Response Dawn O’Connell wrote in a blog post late last month.”
To read more, click here.
(Source: Endpoints, September 9th, 2022)